Olopatadine
CAS 113806-05-6 12 FDA-DMF suppliersSmall Molecule
Overview
Olopatadine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1189432).
API suppliers (12)
Suppliers of Olopatadine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- CURIA SPAIN SAUSpain2 active DMF
- PCASFrance1 active DMF
- INDOCO REMEDIES LTD1 active DMF
- USV PRIVATE LTD1 active DMF
- MSN Laboratories Private LimitedIndia1 active DMF
- PCASFrance1 active DMF
- INDOCO REMEDIES LTD1 active DMF
- USV PRIVATE LTD1 active DMF
- MSN Laboratories Private LimitedIndia1 active DMF
- Kyowa Kirin Co., Ltd.Japan
- APOTEX PHARMACHEM INC
- CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD
Patent & exclusivity (US)
Per the FDA Orange Book (25 approved US products), the latest listed US patent on Olopatadine expires 18 May 2032. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid
- Canonical SMILES
- CN(C)CC/C=C\1/C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
- InChIKey
- JBIMVDZLSHOPLA-LSCVHKIXSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.